A new study reports growth factor could have regenerative effects for those with Parkinson's disease.
A new study reports people who have a family history of alcohol use disorder release more dopamine in the ventral striatum as a response to the expectation of receiving an alcoholic drink than those without a family history of alcoholism.
A new neuroimaging study reveals 12 people with documented post-treatment Lyme disease syndrome have an elevation of a chemical marker associated with neuroinflammation. The findings could help develop new treatments for the pain, fatigue and brain fog associated with PTLDS.
Autotaxin predicts type 2 diabetes and cognitive decline, a new study reports.
Big data finds changes in blood flow mark the earliest sign of Alzheimer's. Additionally, the study found cognitive changes begin earlier in the disease progression than thought.
A new blood test for Alzheimer's disease is up-to 94% accurate at predicting dementia before symptoms appear. The test's accuracy is increased when genetic predisposition and age are taken into account. The new test may eventually replace PET neuroimaging, currently considered the gold standard, for early detection of Alzheimer's.
Researchers have succeeded in passing an antibody through the blood-brain barrier to act as a tracer for PET neuroimaging.
A new study reports people with insulin resistance, a feature common in type 2 diabetes, can increase the risk for developing Alzheimer's disease.
Researchers report deep brain stimulation has little benefit for those suffering from early onset Alzheimer's disease.
PET neuroimaging reveals super-agers and those whose cognitive skills are above the norm for an advanced age have an increased resistance to tau and amyloid proteins.